Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.23 - $9.51 $31,150 - $47,550
5,000 Added 28.74%
22,400 $158,000
Q2 2024

Aug 15, 2024

BUY
$5.9 - $8.02 $102,660 - $139,548
17,400 New
17,400 $113,000
Q2 2023

Aug 11, 2023

SELL
$9.99 - $18.27 $552,447 - $1.01 Million
-55,300 Reduced 51.01%
53,100 $666,000
Q1 2023

May 16, 2023

BUY
$15.0 - $22.76 $1.63 Million - $2.47 Million
108,400 New
108,400 $1.79 Million
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $1.19 Million - $2.06 Million
65,600 New
65,600 $1.47 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $614M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.